Good MorningEquity markets started Tuesday's session on an uncertain footing after tensions in Ukraine escalated. However, the market quickly regained footing to confirm support at a critical level, aligning with the election-inspired rally two weeks ago. With this in play, the odds are high that the election-driven rally is not over and that the S&P 500 index will soon set a new high.
Results from Walmart aided the market rebound. The world's largest employer outpaced consensus on the top and bottom lines and raised its guidance, citing resilient consumer health and steady spending. The news suggests the holiday shopping season will be merry and bright, lifting Walmart's stock price by 5% to set a new all-time high. Analysts are lifting their targets for WMT stock, which may continue to trend higher through the end of the year. Featured: Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid (Ad) 
|
Energy | |
The ultimate goal of a business is to generate cash for its shareholders. Investors often consider net income the “bottom line” of a business, indicating how much profit it makes. Net income equals revenue minus expenses. However, some types of revenue and some types of expenses don&rs... Read the Full Story |
|
From Our Partners | | Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge.
Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks.
Stream his free presentation to get every buy and sell recommendation with no membership or credit card required. | | Watch Marc Chaikin's free presentation and get his full buy-and-sell list today |
|
Technology | | In an industry often characterized by high growth rather than dividend income, finding semiconductor companies that offer both can be particularly appealing. Below are three semiconductor stocks that provide investors with dividend payouts and have recently announced notable increases. I’ll re... Read the Full Story |
|
Consumer Staples | |
While Target (NYSE: TGT) has been a bellwether of retail sector health in recent years, it is not today. The company’s lackluster results are due to its operational quality and lack of relevance in an environment where consumers are budget-conscious. Results from other retailers, including... Read the Full Story |
|
From Our Partners | | TradeSmith CEO Keith Kaplan warns that AI's rapid rise has a dark side, threatening American jobs and livelihoods. He says now is the time to prepare before September 30th.
TradeSmith has invested $17 million in AI tools and built a platform used by 180,000 traders worldwide. One user, Stephen, credits it with building a $2.95 million retirement portfolio. | | See where Kaplan says to move your money before September 30th |
|
Consumer Discretionary | |
Williams-Sonoma (NYSE: WSM) offers everything an investor could want and more, making it a stock worthy of buy-and-hold status. Its quality is centered on the brand and operations, which CEO Laura Alber stewards. The results of her tenure include growth, operational improvement, market share gain,... Read the Full Story |
|
Markets | |
For conservative investors seeking steady income and long-term growth, dividend ETFs offer a reliable "buy and hold" strategy. These funds provide diversification, consistent payouts, and the ease of passive management, making them ideal for a stable, hands-off portfolio. With careful selection, d... Read the Full Story |
|
From Our Partners | | Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required.
Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away. | | Discover the gold income fund before the next payout date |
|
Consumer Discretionary | |
Warren Buffett recently made news about the stocks that Berkshire Hathaway Inc. (NYSE: BRK.B) sold. But it looks like Buffett isn’t sitting this rally out completely. On November 15, Buffett made two significant purchases in two stocks that the company had not previously owned. The stocks we... Read the Full Story |
|
Technology | |
Impinj (NASDAQ: PI) is a mid-cap chip stock that has quietly had a great year in 2024. The stock has returned over 93%, placing it among the top five best returning semiconductor stocks in the United States. Wall Street analysts remain bullish on the stock. The average of the seven price targets... Read the Full Story |
|
Communication Services | |
Advertising technology (adtech) giant The Trade Desk Inc. (NASDAQ: TTD) is the leading independent demand-side platform (DSP) for programmatic advertising. The company’s artificial intelligence (AI) powered adtech platform, Kokai, enables brands and marketers to specify and target the exact ... Read the Full Story |
|
Consumer Discretionary | |
The pandemic triggered a boom in stocks that accommodated physical isolation, convenient access from home, and fitness. Many of these stocks hit unbelievable highs during the lockdowns but collapsed just as hard in the post-pandemic normalization period afterward. While many of these stocks faded ... Read the Full Story |
|
Consumer Discretionary | |
Dutch Bros Inc. (NYSE: BROS) is a thriving drive-thru coffee shop operator and franchisor operating 950 shops across 18 states. While primarily focused on coffee drinks, they also offer teas, smoothies, protein and energy drinks. They prioritize speed and efficiency with an app-driven, drive-thru-... Read the Full Story |
|
Thursday's Early Bird Stock Of The Day Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases in the United States, the United Kingdom, and internationally. The company's lead product includes fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors and hematological malignancies, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and Plogosertib, a polo-like kinase inhibitor program, which is in Phase 1/2 clinical trial for the treatment of advanced solid tumors and hematological malignancies. It has a clinical collaboration agreement with the University of Texas MD Anderson Cancer Center to clinically evaluate the safety and efficacy of three cyclacel medicines in patients with hematological malignancies, including chronic lymphocytic leukemias, acute myeloid leukemias, myelodysplastic syndromes, and other advanced leukemias. The company was founded in 1996 and is headquartered in Berkeley Heights, New Jersey. | | View Today's Stock Pick |
|
